1.24
price down icon2.36%   -0.03
pre-market  시장 영업 전:  1.24  
loading

Acrivon Therapeutics Inc 주식(ACRV)의 최신 뉴스

pulisher
02:38 AM

Best data tools to analyze Acrivon Therapeutics Inc. stockIntraday Strategy with Real Time Monitoring - Newser

02:38 AM
pulisher
Aug 10, 2025

Leading vs lagging indicators on Acrivon Therapeutics Inc. performanceSmart Chart Forecasting with AI Algorithms - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Real time alert setup for Acrivon Therapeutics Inc. performanceTechnical Insight Guide for Safer Trades - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

How to integrate Acrivon Therapeutics Inc. into portfolio analysis toolsFree AI Driven Stock Trend Forecast - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Acrivon Therapeutics (ACRV) Expected to Announce Earnings on Tuesday - Defense World

Aug 10, 2025
pulisher
Aug 10, 2025

Momentum divergence signals in Acrivon Therapeutics Inc. chartFree Real Profit Trade Plan Suggestions - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

How to recover losses in Acrivon Therapeutics Inc. stockFree Reversal Alert Based on RSI Indicator - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

How Acrivon Therapeutics Inc. stock performs during market volatilityFree Consistent Profit Pattern Recognition Tools - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

What makes Acrivon Therapeutics Inc. stock price move sharplyTriple Digit Gain Opportunity Watchlist - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Statistical indicators supporting Acrivon Therapeutics Inc.’s strengthEntry Confirmation Using Short-Term Forecasting - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

Is Acrivon Therapeutics Inc. stock a good hedge against inflationSmart Trend Analysis With Buy Point Cues - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Real time breakdown of Acrivon Therapeutics Inc. stock performanceAI Triggered Buy Zone Forecast System - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Short interest data insights for Acrivon Therapeutics Inc.Free Triple Digit Growth Focused Trade Plan - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Acrivon Therapeutics, Inc. (NASDAQ:ACRV) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Aug 08, 2025
pulisher
Aug 07, 2025

How high can Acrivon Therapeutics Inc. stock price go in 2025Free Secure Return Focused Investment Plan - Newser

Aug 07, 2025
pulisher
Aug 07, 2025

What moving averages say about Acrivon Therapeutics Inc.Early Entry Ideas with Momentum Potential - Newser

Aug 07, 2025
pulisher
Aug 07, 2025

Tools to monitor Acrivon Therapeutics Inc. recovery probabilityFree Profit Target Stock Opportunity Monitor - Newser

Aug 07, 2025
pulisher
Aug 06, 2025

Why Acrivon Therapeutics Inc. stock attracts strong analyst attentionFree AI Driven Buy Alert Trade Blueprint - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Using economic indicators to assess Acrivon Therapeutics Inc. potentialHigh Yield Watchlist with Filtered Picks - Newser

Aug 06, 2025
pulisher
Aug 05, 2025

Detecting support and resistance levels for Acrivon Therapeutics Inc.Trade Setup Builder with Custom Alerts - Newser

Aug 05, 2025
pulisher
Aug 05, 2025

Will breakout in Acrivon Therapeutics Inc. lead to full recoveryRisk Balanced Picks for Safer Trading - Newser

Aug 05, 2025
pulisher
Aug 04, 2025

Candlestick Reversal Detected on Acrivon Therapeutics Inc.’s ChartShort Term Buy Zone Stock Alerts Signal Entry - metal.it

Aug 04, 2025
pulisher
Aug 03, 2025

Cantor Fitzgerald sets Acrivon stock to Overweight on AP3 platform - MSN

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Acrivon Therapeutics Inc. stockStrongest growth potential - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

When is Acrivon Therapeutics Inc. stock expected to show significant growthFree Consultation - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does Acrivon Therapeutics Inc. generate profit in a changing economyFree Investment Timing Strategies - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What analysts say about Acrivon Therapeutics Inc. stockTrack top-performing stocks in real-time - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What catalysts could drive Acrivon Therapeutics Inc. stock higher in 2025Outstanding capital appreciation - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Acrivon Therapeutics Inc. stock overvalued or undervaluedMaximize gains with data-driven stock picks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Acrivon Therapeutics Inc. a growth stock or a value stockMaximize portfolio value with smart investment plans - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Acrivon Therapeutics Inc. stock in 2025Explosive earning power - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

How does Acrivon Therapeutics Inc. compare to its industry peersAccess high-quality stock research instantly - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are analysts’ price targets for Acrivon Therapeutics Inc. in the next 12 monthsMaximize returns with disciplined trading approaches - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are the technical indicators suggesting about Acrivon Therapeutics Inc.Get daily updates on the hottest stocks - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

What is Acrivon Therapeutics Inc. company’s growth strategySmart Portfolio Data Feed For 2025 - Jammu Links News

Aug 01, 2025
$78.39
price up icon 0.24%
$37.58
price up icon 1.54%
$109.55
price up icon 0.23%
$28.66
price up icon 2.10%
$111.66
price up icon 0.28%
biotechnology ONC
$288.18
price down icon 3.39%
자본화:     |  볼륨(24시간):